Press Release
Procaps Group Acquires 1st U.S.-Based Softgel Production Facility under the name Sofgen Pharmaceuticals, expanding its iCDMO Business
As a leading pharmaceutical group, Procaps is focused on the expansion of its iCDMO business, offering integrated, end-to-end solutions in innovative softgel dosage forms from development across delivery to the pharmaceutical and nutraceutical industries.
With the acquisition of this new facility located in West Palm Beach, Florida, our Sofgen business will provide the opportunity to deliver a wider product array in our innovative softgel technologies for companies interested in launching new products within North America and other Highly regulated markets as we move even closer to our customers and prospects, improving our supply chain efficiency, providing greater flexibility, reliability, time-to-market, fueled by growth and innovation.
